Physician profile
Jonathan Balog
NPI 1417214289
$884.88
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $551 · 2020: $205 · 2021: $62.09 · 2022: $19.67 · 2023: $47.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $47.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $47.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $141.25 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $107.25 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $88.27 | 2019-2020 | |
| Exact Sciences Corporation | $47.09 | 2023 | Cologuard Collection Kit |
| Astellas Pharma US INC | $42.42 | 2019 | |
| Abbott Laboratories | $38.41 | 2019-2020 | |
| Lilly USA, LLC | $36.42 | 2019-2020 | |
| Allergan, INC. | $35.09 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $32.48 | 2020 | |
| Coloplast Corp | $29.02 | 2020 | |
| Genentech USA, INC. | $27.70 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $27.46 | 2019-2020 | |
| Pfizer INC. | $26.92 | 2019 | |
| Abbvie INC. | $26.66 | 2021 | |
| Glaxosmithkline, LLC. | $26.13 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalpropion Pharmaceuticals LLC | $25.93 | 2019 | |
| Gilead Sciences, INC. | $19.12 | 2019 | |
| Phadia US INC. | $18.12 | 2019 | |
| Horizon Therapeutics Plc | $17.55 | 2020 | |
| Ibsa Pharma INC. | $16.86 | 2020 | |
| Dermira, INC. | $16.21 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.19 | 2021 | |
| Amarin Pharma, INC. | $11.77 | 2019 | |
| Ironshore Pharmaceuticals INC. | $11.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Balog listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.